Howard University
From the SelectedWorks of Clarence Lee

May, 2004

Amebiasis and comparison of microscopy to
ELISA technique in detection of Entamoeba
histolytica and Entamoeba dispar
Clarence Lee, Howard University

Available at: https://works.bepress.com/clarence-lee/1/

AMEBIASIS AND COMPARISON OF
MICROSCOPY TO ELISA TECHNIQUE IN
DETECTION OF ENTAMOEBA HISTOLYTICA
AND ENTAMOEBA DISPAR
Rose A. Nesbitt, PhD; Franklin W. Mosha, PhD; Hormuzd A. Katki, MS;
Mohammad Ashraf, PhD; Charles Assenga, MS; and Clarence M. Lee, PhD
Washington, DC; Moshi, Tanzania; and Baltimore, Maryland

Summary: The analysis of records of amoebal infection in various hospitals in Kilimanjaro indicated frequent occurrence of amebiasis. The population over the age of five years had higher rate
of amoebal infection compared to less than that of a five-year-old population; however, both age
groups had similar patterns of amebiasis during January 1999 to June 2001. To investigate misdiagnosis of amebiasis, 226 patients (passive cases) in three hospitals and 616 individuals (active
cases) from three different localities in Kilimanjaro were examined. In passive cases, the prevalences of Entamoeba histolytica and Entamoeba dispar were 1% and 7.3%, respectively. Among
active cases, 1% were infected with E. histolytica, and 15% were infected with E. dispar. There
were no significant differences in amoebal infection between the male and female populations. A
pool of 842 stool samples was used for diagnosis of E. histolytica and E. dispar by microscopic
examination or ELISA kits. The microscopic examination indicated 8.7% amoebal infection; however, using ELISA as the gold standard, the prevalence of histolytica/dispar was 0.8% and 7.4%,
respectively. This study indicated that E. dispar infection was 14.5 times more prevalent than E.
histolytica infection. (J Natl MedAssoc. 2004;96:671-677.)
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INTRODUCTION
In human amebiasis, the differentiation of the
invasive parasite Entamoeba histolytica from the
commensal organism Entamoeba dispar is of great
concern to the medical community. Amebiasis is
transmitted by fecal contamination of drinking
water and foods, direct contact with dirty hands or
objects, anal sexual contact, and poor sanitation
and hygiene. For many years E. histolytica and E.
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dispar have been known to be two distinct species.
The description of E. dispar by Brumpt' was dismissed as a synonym of E. histolytica. However,
later evidence mounted in support of Brumpt's
description of E. dispar as a separate species.2-8 E.
histolytica and E. dispar are genetically distinct but
closely related protozoan species. Both colonize
the human gut, but only E. histolytica is able to
invade tissues leading to massive and sometimes
lethal pathological alterations, such as ulcerative
colitis or abscesses of various organs-most commonly, the liver.9
Infections of E. histolytica and E. dispar are
often diagnosed by demonstrating cysts or trophozoites in a stool sample. A great number of methods for distinguishing E. histolytica from E. dispar
have now been described in the literature.23'0'
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Sargeaunt'° looked at a database of several thousand isolates from all over the world and grouped
all E. histolytica into one of two groups: i) pathogenic E. histolytica and ii) nonpathogenic E. histolytica. This division was further supported by
antigenic differences" and differences in the DNA.5
By 1993, a lot of evidence was available to distinguish E. histolytica from E. dispar and was formally redescribed.A The World Health Organization
expert committee endorsed the redescription of the
two species.'2"3 Since then, an ELISA specific for
E. histolytica has been developed for fecal-antigen
detection. This technique detected all cases of
amoebic dysentery.'4 Also, there is a fecal-antigen
detection test, which is based on a monoclonal
antibody against galactose-inhibitable lectin on the
surface of E. histolytica.'5 An ELISA-based technique in which PCR products are detected with
dioxigenin-labeled primers has been developed to
differentiate between E. histolytica and E. dispar.'6
The tests, based on nucleic acid detection to differentiate the two species, are being used in a routine
reference diagnostic service for cyst carriers.'7
E. histolytica or E. dispar infect half a billion
people annually,'5"8 with 90% being asymptomatic
and the remaining 10% accounting for the third
most common cause of death from parasitic disease in the world. Additional health effects of ameTable 1. Detection of amoebal infection
(histolyticaldispor) among 842 subjects using
Entamoeba Test (TechLab). The sensitivity
(39%) and specificity (96%) were determined
using dichotomous approach. The amoebal
infection was 8.2%, and infection missed by
microscope was 61%.
Test Results
Positive
Negative
Total

Infected
27
42
69

Not Infected
32
741
773

Total
59
783
842

Sensitivity = 39%; Specificity = 96%
Positive predictive value = 46%
Negative predictive value = 95%
Infection missed by microscope:
1- sensitivity = 61%
Fraction unnecessarily treated:
1- specificity = 4%
Fraction with amoebal infection
(dispar/histolytica) = 8.2%
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biasis are delayed treatment of other related diarrheal diseases due to misdiagnosis of E. histolytica
when conventional microscopic methods are
employed. The immunological diagnostic tests can
specifically differentiate between these two related
species.
The present study was carried out to examine
the prevalence and etiological agent of amebiasis in
Kilimanjaro, Tanzania. The main aim of this study
was to demonstrate the importance of correctly
identifying E. histolytica in order to avoid unnecessary treatment costs and delayed treatment of actual infection.

MATERIALS AND METHODS
Study Areas
The study was carried out in the foothills of
Mount Kilimanjaro in Tanzania. Residents in this
area are mainly engaged in coffee and banana
farming. The main source of water is microbialcontaminated furrow water from rivers flowing
from the mountain springs. The Kilimanjaro area is
considered an endemic area for amebiasis in the
tropics. Other diseases in this area from the records
of health centers include malaria, upper respiratory
infections, diarrheal diseases, and intestinal
worms. Three villages (Rundugai, Mabogini, and
Mvuleni) with an average population of 5,000 and
Table 2. Detection of E. histolytica infection
among 842 subjects using E. histolytica-ll Test
(TechLab). The sensitivity (43%) and specificity
(93%) were determined using dichotomous
approach. The E. histolytica infection was
0.8%, and infection missed by microscope was
57%.
Test Results
Positive
Negative
Total

Infected
3
4
7

Not Infected
56
779
835

Total
59
783
842

Sensitivity = 43%; Specificity = 93%
Positive predictive value = 5%
Negative predictive value = 99.5%
Infection missed by microscope:
1- sensitivity = 57%
Fraction unnecessarily treated:
1- specificity = 7%
Fraction with E. histolytica infection = 0.8%
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one health center were selected for active cases
(people who were not sick/no symptoms of infection). Three hospitals (Kibosho, Kilimanjaro Christian Medical College, and Kibongoto) were included in this study for passive cases (people who had
symptoms of amoebal infection). Information relating to population structure; disease cases; possible
sources of amoebal infection; personal hygiene;
history of amebiasis; and the source of drinking,
cooking, and washing water was obtained from the
health center serving the area.

Data on Amoebal Infection
in Hospitals
Data on amoebal infection in various hospitals in
Kilimanjaro during January 1999 to June 2001 were
collected and analyzed as percent rate of infection.
The amoebal infection diagnosis in these hospitals
was based on the microscopic examination. On
average, 500 patients under and above five years old
were examined for amoebal infection.

Collection of Stool Samples
The study population was divided into groups:
1) 616 active cases included individuals who were
requested to report to their health center for routine
examination of intestinal parasites, and 2) 226 passive cases included individuals who reported in
three hospitals with diarrheal problems. The mornTable 3. Detection of E. dispar among 842
subjects using Entamoeba Test minus E.
histolytica-ll Test (TechLab). The sensitivity (39%)
and specificity (96%) were determined using
dichotomous approach. The E. dispar infection
was 7.4%, and infection missed by microscope
was 61%.
Test Results
Positive
Negative
Total

Infected
24
38
62

Not Infected
35
745
780

Total
59
783
842

Sensitivity = 39%; Specificity = 96%
Positive predictive value = 41%
Negative predictive value = 95%
Infection missed by microscope:
1- sensitivity = 61%
Fraction unnecessarily treated:
1- specificity = 4%
Fraction with E. dispar infection = 7.4%
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ing stool samples were collected in special stool
containers. All stool samples were labeled and
brought to the Kilimanjaro Christian Medical College laboratory in cool boxes for examination within 24 hours of collection. For each stool sample,
color, consistency, and presence of blood or mucus
were recorded. A pool of 842 stool samples was
used for diagnosis of E. histolytica and E. dispar
by microscopic examination or monoclonal ELISA
kits (TechLab, Corporate Research Park, Blacksburg, VA). Each sample was divided into four parts
and used for: 1) microscopic examination, 2) Entamoeba Test-E. histolytica plus E. dispar, 3) E.
histolytica test, and 4) possible repeat test.

Microscopic Examination
Lugol's iodine was added to the stool smear and
covered with a cover slip and examined within
five- to 15 minutes using the lOOX objective.
Detailed processing and examination procedures
were as described by Bailey.'9 During examination,
all observed parasites were recorded.

Entamoeba Test Versus
E. Histolytica 11 Test
The Entamoeba Test and the E. histolytica II Test
(gold standard) were used. These two tests are based
on a monoclonal antibody against galactose adhesions distinct epitopes of E. histolytica or E. dispar,
which do not cross-react serologically and are used
for the rapid detection of the parasites in stools. The
Entamoeba Test (sensitivity and specificity of
87.7% and 98.3%, respectively) is designed to
detect but not differentiate the antigens of E. histolytica and E. dispar in stool. The E. histolytica II
Test (sensitivity and specificity of 96.9% and
100%, respectively) is designed to detect specifically E. histolytica in stool. The Entamoeba Test was
performed on all the stool specimens. The E. histolytica II Test was performed only on those specimens which were positive with the Entamoeba Test.
As specified earlier, a total of 616 (active cases) and
226 (passive cases) stool samples (less than 24
hours old) were analyzed.
Each stool sample was thoroughly mixed prior
to performing the assay. This included vortexing of
the stool sample prior to transfer to the diluent, and
complete mixing of the diluted stool sample prior
to transfer to the microwell. The diluent was formulated to stabilize the adhesin in the stool sample
and minimize degradation. The diluted stool samVOL. 96, NO. 5, MAY 2004 673
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ple was stored at 2-8°C until the test was performed. It has been found that under these conditions, the stool sample remained positive when
tested daily over a period of five days.

and ELISA tests, the sensitivity and specificity,
positive predictive value (PPV) and negative predictive values (NPV) were computed-assuming that
the ELISA test can adequately serve as a gold standard, although there is no specific ELISA test for E.
dispar alone. It can be determined from the results
of both ELISA tests on a stool sample. So the total
number ofthose with E. dispar is the number which
test positive on the Entamoeba Test minus the number which test positive on the E. histolytica-IJ Test.
Since the examination by microscopy cannot distinguish between the two amoeba, therefore, the total
number of positive and negative microscopic diagnosis is the same for E. histolytica infection. Using
these facts, the sensitivity and specificity, PPV, and
NPV for E. histolytica and E. dispar have been
computed using a dichotomous approach.20

Preparation of the Stool for
Monoclonal ELISA
One vial for each sample to be tested was set up.
A 0.4-ml diluent was added to each vial labeled
directly on the side and vortexed to ensure adequate mixing. For formed stools 0. 15-0.20 g and
for liquid stools, 0.4 ml were used. The stools were
vortexed before being transferred to their respective labeled vials. The vials were vortexed for 10
seconds and stored at 2-8°C until ELISA was performed. The specimens were vortexed again before
transferring the diluted specimen to the wells.
The test procedure for monoclonal ELISA was
performed as described in the TechLab manual. A
test sample was considered positive if it had an
obvious yellow color when compared to the negative control well. A test sample was considered
negative if the reaction was colorless. If the yellow
was not distinct, the test was repeated.

RESULTS
The analysis of the records of amoebal infection
in various hospitals in Kilimanjaro indicated frequent occurrence of amebiasis. The results of this
study indicated that the population over the age of
five years had a higher rate of amoebal infection
compared to the population under the age of five
years. However, both age groups had similar patterns of amoebal infection throughout the study
period (Figure 1). This study indicated that females
over the age of five had a higher rate of infection

STATISTICAL ANALYSIS
To compare the percentage differences among
various groups, the mean percent rate of infections
was calculated. To compare the microscopic test

Figure 1. Percent rate of amoebal infection in the different age groups among the people of
Kilimanjaro, Tanzania. The rate of amoebal infection was higher in persons older than five years.
However, the infection rate pattern was the same in both groups.
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during February-March of 2000. However, during
February-March of 2001, males over the age of five
had a higher rate of infection, which remained high
until the middle of the year; otherwise, there was no
significant difference in the amoebal infection
between the male and female populations (Figure 2).
The frequency of E. histolytica infection in both
passive and active cases was 1%, while the prevalence of E. dispar was 7.3% among passive cases
and 15% among active cases.
The detection of amoebal infection with the
microscopy was compared to the ELISA test. The
sensitivity and specificity of microscopy technique
were 39% and 96%, respectively, while the PPV
and NPV were 46% and 95%, respectively. The
total amoebal infection was 8.2%, and the detection of amoebal infection missed by microscopy
was 61% (Table 1). In detecting only E. histolytica
infection, microscopy sensitivity and specificity
were 43% and 93%, respectively. The PPV and
NPV were 5% and 99.2%, respectively. The total E.
histolytica infection was only 0.8%, and the detection of E. histolytica infection missed by
microscopy was 57% (Table 2). In detecting only
E. dispar, the sensitivity and specificity were 39%
and 95%, respectively. The PPV and NPV for E.
dispar were 41.1% and 94.7%, respectively. The
total E. dispar infection was 7.4%, and the detec-

tion of E. dispar infection missed by microscopy
was 61%. (Table 3). This study indicated that E.
dispar infection was 14.5 times more prevalent
than E. histolytica infection, and the proportion of
E. histolytica infection in the population is 7%.

DISCUSSION
Since microscopic examination cannot distinguish with certainty between E. dispar and E. histolytica parasites, the amoebal infection detected
with the microscope wrongly overestimated the
number of people infected with E. histolytica. Even
if the microscope test is positive for E. histolytica, it
is still highly likely (1 -PPV=95%) that the patient
does not have E. histolytica infection. However,
when microscopic examination revealed negative
results, then E. histolytica infection is very unlikely.
The ELISA technique is considered an ideal
gold standard with which microscopy technique is
compared. Although the ELISA technique cannot
perfectly distinguish between E. histolytica and E.
dispar, it has excellent sensitivity, specificity, PPV,
and NPV On the other hand, microscopic examination gives more false positives, and has low sensitivity (50%) and exceedingly low PPV (3.6%).
The observed prevalence of 0.8% and 7.4% for
E. histolytica and E. dispar, respectively, for amebiasis in Kilimanjaro confirms the postulated idea

Figure 2. Showing the differences in the percent rate of amoebal infection between male and female
populations of Kilimanjaro, Tanzania. Both sexes had the same pattern of amoebal infections. The
amebiasis was more prevalent during 2000 and 2001,5 compared to 1999.
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by Clark"8 that the pathogenic amoeba (E. histolytica) is only about 10% of all amoebal infections.
Although metronidazole is effective in treating E.
histolytica infection, it has side effects and is
expensive. In addition, there is a possibility of
developing resistance to the drug through widespread and unnecessary use. The use of metronidazole is intended only for elimination of tissue-invasive organisms and is not effective against
intestinal lumen infections.2' Metronidazole was
given for the treatment of nonpathogenic E. dispar,
which also delayed the treatment for the actual
cause of illness. The cost of this unnecessary treatment was calculated in one of the Kibosho's hospitals for passive cases. The total number ofE. dispar
infected patients was 3,539 over the period of three
years (1,416 patients per year), and the cost of
metronidazole (twice a day for seven days) in U.S.
dollars was $16.19 per patient. Therefore, the cost
of treating E. dispar infection at Kibosho hospital
was $22,918.60 per year, which was considered
very expensive in the country where the majority
of people earn less than $1 U.S. per day. The question is, would it be cost-effective to switch to the
ELISA test? The answer is not clear. However, it
will reduce unnecessary treatment. The experts on
amebiasis22 supported development and use of
alternative diagnostic methods for both clinical and
epidemiological studies-most of which have been
rendered absolute by differentiation of the two similar species. The expert committee further recommended that, ideally, E. histolytica should be
specifically identified and treated.
The cases reported for amebiasis are usually a
mixture of pathogenic E. histolytica and nonpathogenic E. dispar, resulting from reliance of conventional microscopic diagnostic methods. Simple, inexpensive diagnostic tests for distinguishing E.
histolytica infections from those with E. dispar are
needed to reduce unnecessary drug prescription and
to allow for collection of accurate prevalence and
incidence data. The prevalence of E. histolytica infection is often quoted at 10% of the world population or
500 million infections.23 This is obviously misleading, if 90% of these infections are due to E. dispar.
Why is E. dispar important despite the fact that
it does not cause disease? Part of the answer lies in
the realm of diagnosis. In endemic areas, E. dispar
is by far the more prevalent species by a ratio of
perhaps as much as 10:1.I8,24-27 In Europe and North
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America, where invasive amebiasis is rare, almost
all infections previously ascribed to E. histolytica
were in fact due to E. dispar.10"4'28'29 The significance of this is that in most cases, there is no need
for antiparasitic agents to be administered. Indeed,
the new WHO recommendation12'13 specifically
states that drug treatment is not recommended
unless E. histolytica is unequivocally shown to be
present or if there is strong reason to suspect that
the patient may be carrying E. histolytica and not
E. dispar.
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